These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37866818)

  • 1. Metabolic effects of atypical antipsychotics: Molecular targets.
    Fonseca M; Carmo F; Martel F
    J Neuroendocrinol; 2023 Dec; 35(12):e13347. PubMed ID: 37866818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences.
    Carli M; Kolachalam S; Longoni B; Pintaudi A; Baldini M; Aringhieri S; Fasciani I; Annibale P; Maggio R; Scarselli M
    Pharmaceuticals (Basel); 2021 Mar; 14(3):. PubMed ID: 33800403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotics-induced metabolic alterations: Recounting the mechanistic insights, therapeutic targets and pharmacological alternatives.
    Singh R; Bansal Y; Medhi B; Kuhad A
    Eur J Pharmacol; 2019 Feb; 844():231-240. PubMed ID: 30529195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical antipsychotics-induced metabolic syndrome and nonalcoholic fatty liver disease: a critical review.
    Xu H; Zhuang X
    Neuropsychiatr Dis Treat; 2019; 15():2087-2099. PubMed ID: 31413575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences.
    Aringhieri S; Carli M; Kolachalam S; Verdesca V; Cini E; Rossi M; McCormick PJ; Corsini GU; Maggio R; Scarselli M
    Pharmacol Ther; 2018 Dec; 192():20-41. PubMed ID: 29953902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.
    Sikirica V; Pliszka SR; Betts KA; Hodgkins P; Samuelson T; Xie J; Erder H; Dammerman R; Robertson B; Wu EQ
    J Manag Care Pharm; 2012; 18(9):676-89. PubMed ID: 23206211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotics-induced metabolic alterations: focus on adipose tissue and molecular mechanisms.
    Gonçalves P; Araújo JR; Martel F
    Eur Neuropsychopharmacol; 2015 Jan; 25(1):1-16. PubMed ID: 25523882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herbal Therapies for Weight Gain and Metabolic Abnormalities Induced by Atypical Antipsychotics: A Review Article.
    Naghibi H; Salari R; Yousefi M; Khadem-Rezaiyan M; Ghanbarzadeh MR; Fayyazi Bordbar MR
    Curr Drug Discov Technol; 2023; 20(5):e110423215660. PubMed ID: 37055899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of metabolic syndrome in schizophrenia and implications for antipsychotic therapy : is there a role for folate?
    Burghardt KJ; Ellingrod VL
    Mol Diagn Ther; 2013 Feb; 17(1):21-30. PubMed ID: 23341251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between SCAP and SREBF1 gene polymorphisms and metabolic syndrome in schizophrenia patients treated with atypical antipsychotics.
    Yang L; Chen J; Li Y; Wang Y; Liang S; Shi Y; Shi S; Xu Y
    World J Biol Psychiatry; 2016 Sep; 17(6):467-74. PubMed ID: 26982812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential mechanisms of atypical antipsychotic-induced hypertriglyceridemia.
    Yan H; Chen JD; Zheng XY
    Psychopharmacology (Berl); 2013 Sep; 229(1):1-7. PubMed ID: 23832387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical antipsychotics: A review on the prevalence, monitoring, and management of their metabolic and cardiovascular side effects.
    Wei Xin Chong J; Hsien-Jie Tan E; Chong CE; Ng Y; Wijesinghe R
    Ment Health Clin; 2016 Jul; 6(4):178-184. PubMed ID: 29955467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic Safety of Atypical Antipsychotics: Current Evidence and Future Directions.
    Slim M; Medina-Caliz I; Gonzalez-Jimenez A; Cabello MR; Mayoral-Cleries F; Lucena MI; Andrade RJ
    Drug Saf; 2016 Oct; 39(10):925-43. PubMed ID: 27449495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety and tolerability of atypical antipsychotics in bipolar disorder.
    Seemüller F; Forsthoff A; Dittmann S; Born C; Bernhard B; Severus WE; Grunze H
    Expert Opin Drug Saf; 2005 Sep; 4(5):849-68. PubMed ID: 16111448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical antipsychotics and glucose homeostasis.
    Bergman RN; Ader M
    J Clin Psychiatry; 2005 Apr; 66(4):504-14. PubMed ID: 15816794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotic-Induced Metabolic Syndrome: A Review.
    Akinola PS; Tardif I; Leclerc J
    Metab Syndr Relat Disord; 2023 Aug; 21(6):294-305. PubMed ID: 37347965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormalities of glucose metabolism associated with atypical antipsychotic drugs.
    Newcomer JW
    J Clin Psychiatry; 2004; 65 Suppl 18():36-46. PubMed ID: 15600383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.